Light activates reduction of methotrexate by NADPH in the ternary complex with Escherichia coli dihydrofolate reductase

Photochemistry and Photobiology

Volumn 69, Issue 1, 1999, Pages 77-85

  Chen, Yong Qing ^a,d   Gulotta, Miriam ^b   Cheung, H T Andrew ^c   Callender, Robert ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI;

DIHYDROFOLATE REDUCTASE; FOLIC ACID ANTAGONIST; METHOTREXATE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CHEMISTRY; ENZYMOLOGY; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; LIGHT; METABOLISM; OXIDATION REDUCTION REACTION; PHOTOCHEMISTRY; RADIATION EXPOSURE;

ESCHERICHIA COLI; FOLIC ACID ANTAGONISTS; HUMANS; LIGHT; METHOTREXATE; NADP; OXIDATION-REDUCTION; PHOTOCHEMISTRY; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0032603483     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1999.tb05309.x     Document Type: Article

References (57)

1. Nirenberg, A., C. Mosende, B. M. Mehta, A. L. Gisolfi and G. Rosen (1977) High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity. Cancer Treat. Rep. 61, 779-783.
2. Von Hoff, D. D., J. S. Penta, L. J. Helman and M. Slavik (1977) Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration. Cancer Treat. Rep. 61, 745-748.
3. Drake, J. C., C. J. Allegra, J. Baram, B. T. Kaufman and B. A. Chabner (1987) Effects on dihydrofolate reductase of methotrexate metabolites and intracellular folates formed following methotrexate exposure of human breast cancer cells. Biochem. Pharmacol. 36, 2416-2418.
4. Vaisman, N., V. A. Stallings, H. Chan, S. S. Weitzman, R. Clarke and P. B. Pencharz (1993) Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia. Am. J. Clin. Nutr. 57, 679-684.
5. Jolivet, J., K. H. Cowan, G. A. Curt, N. J. Clendeninn and B. A. Chabner (1983) The pharmacology and clinical use of methotrexate. N. Engl. J. Med. 309, 1094-1104.
6. Korn, S. and R. J. Dehoratius (1989) Methotrexate in the treatment of rheumatoid arthritis. 40, 243-246.
7. White, P. H. and B. M. Ansell (1992) Methotrexate for juevenile rheumatoid arthritis. N. Engl. J. Med. 326, 1077-1078.
8. Blakley, R. L. (1969) The Biochemistry of Folic Acid and Related Pteridines. North-Holland, Amsterdam.
9. Poe, M., N. J. Greenfield, J. M. Hirshfield and K. Hoogsteen (1974) Dihydrofolate reductase from a methotrexate resisitant strain of Escherichia coli: binding of several folates and pteridines as monitored by ultraviolet difference spectroscopy. Cancer Biochem. Biophys. 1, 7-11.
10. Gupta, S. V., F. J. Greenfield, M. Poe, D. R. Makulu, M. N. Williams, B. A. Moroson and J. R. Bertino (1977) Dihydrofolate reductase from a resistant subline of the L1210 lymphoma. Purification by affinity chromatography and ultraviolet difference spectrophotometric and circular dichroic studies. Biochemistry 16, 3073-3079.
11. Hood, K. and G. C. K. Roberts (1978) Ultraviolet difference spectroscopic studies of substrate and inhibitor binding to Lactobacillus casei dihydrofolate reductase. Biochem. J. 171, 357-366.
12. Subramanian, S. and B. T. Kaufman (1978) Interaction of methotrexate, folates, and pyridine nucleotides with dihydrofolate reductase: calorimetric and spectroscopic binding studies. Proc. Natl. Acad. Sci. USA 75, 3201-3205.
13. Cocco, L., C. J. Temple, J. A. Montgomery, R. E. London and R. L. Blakley (1981) Protonation of methotrexate bound to the catalytic site of dihydrofolate reductase from Lactobacillus casei. Biochem. Biophys. Res. Commun. 100, 413-419.
14. Stone, S. R. and J. F. Morrison (1983) The pH dependence of the binding of dihydrofolate and substate analogues to dihydrofolate reductase from Escherichia coli. Biochim. Biophys. Acta 745, 247-258.
15. Greenfield, N. J., M. N. Williams, M. Poe and K. Hoogsteen (1972) Circular dichroism studies of dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli. Biochemistry 11, 4706-4711.
16. Greenfield, N. J. (1975) Circular dichroism studies of dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli B, MB 1428: ternary complexes. Biochim. Biophys. Acta 403, 32-46.
17. Farnum, M. F., D. Magde, E. E. Howell, J. T. Hirai and M. S. Warren (1991) Analysis of hydride transfer and cofactor fluorescence decay in mutants of dihydrofolate reductase: possible evidence for participation of enzyme molecular motions in catalysis. Biochemistry 30, 11567-11579.
18. Saperstein, D. D., A. J. Rein, M. Poe and M. F. Leahy (1978) Binding of methotrexate to Escherichia coli dihydrofolate reductase as measured by visible and ultraviolet resonance Raman spectroscopy. J. Am. Chem. Soc. 100, 4296-4300.
19. Ozaki, Y., R. W. King and P. R. Carey (1981) Methotrexate and folate binding to dihydrofolate reductase. Separate characterization of the pteridine and p-aminobenzoyl binding sites by resonance Raman spectroscopy. Biochemistry 20, 3219-3225.
20. Zheng, J., Y. Q. Chen and R. Callender (1993) A study of the binding of NADP coenzymes to dihydrofolate reductase by Raman difference spectroscopy. Eur. J. Biochem. 215, 9-16.
21. Chen, Y. Q., J. Kraut and R. Callender (1997) pH-Dependent conformational changes in Escherichia coli dihydrofolate reductase revealed by Raman difference spectroscopy. Biophys. J. 72, 936-941.
22. Cocco, L., J. P. Groff, C. J. Temple, J. A. Montgomery, R. E. London, N. A. Matwiyoff and R. L. Blakley (1981) Carbon-13 nuclear magnetic resonance study of protonation of methotrexate and aminopterin bound to dihydrofolate reductase. Biochemistry 20, 3972-3978.
23. Cocco, L., B. Roth, C. J. Temple, J. A. Montgomery, R. E. London and R. L. Blakley (1983) Protonated state of methotrexate, trimethoprim and pyrimethamine bound to dihydrofolate reductase. Arch. Biochem. Biophys. 226, 567-577.
24. 15N nuclear magnetic resonance evidence of the ionization state of substrates bound to bovine dihydrofolate reductase. Biochemistry 29, 1290-1296.
25. 15N NMR studies of the conformation of E. coli dihydrofolate reductase in complex with folate or methotrexate. FEBS Lett. 289, 231-234.
26. 13C NMR studies of complexes of Escherichia coli dihydrofolate reductase formed with methotrexate and with folic acid. FEBS Lett. 312, 147-151.
27. 13C NMR determination of the tautaomeric and ionizations states of folate in its complexes with Lactobacillus casei dihydrofolate reductase. Biochemistry 32, 6846-6854.
28. 31P-shift-correlation experiments. Eur. J. Biochem. 204, 173-177.
29. Gerothanassis, I. P., B. Birdsall, C. J. Bauer, T. A. Frenkiel and J. Feeney (1992) Nuclear magnetic resonance detection of bound water molecules in the active site of Lactobacillus casei dihydrofolate reductase in aqueous solution. J. Mol. Biol. 226, 549-554.
30. 3H-NMR studies of multiple conformations and dynamic processes in complexes of folate and methotrexate with Lactobacillus casei dihydrofolate reductase. Biochem. J. 303, 401-405.
31. 13C resonance assignments, secondary structure, and the conformation of substrate in the binary folate complex of Escherichia coli dihydrofolate reductase. J. Biomol. NMR 4, 349-366.
32. Matthews, D. A., R. A. Alden, J. T. Bolin, S. T. Freer, R. Hamlin, N. Xuong, J. Kraut, M. Poe, M. Williams and K. Hoogsteen (1977) Dihydrofolate reductase: X-ray structure of the binary complex with methotrexate. Science 197, 452-455.
33. Matthews, D. A., R. A. Alden, J. T. Bolin, J. T. Filman, D. J. Freer, R. Hamlin, R. Hol, W. G. J. Kisliuk, R. L. Pastore, E. J. Plante, N. Xuong and J. Kraut (1978) Dihydrofolate reductase from Lactobacillus casei X-ray structure of the enzyme-methotrexate-NADPH complex. J. Biol. Chem. 253, 6946-6954.
34. Bolin, J. T., D. J. Filman, D. A. Matthews, R. C. Hamlin and J. Kraut (1982) Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. J. Biol. Chem. 257, 13650-13662.
35. Cody, V., J. R. Luft, E. Ciszak, T. I. Kalman and J. H. Freisheim (1992) Crystal structure determination at 2.3 A of recombinant human dihydrofolate reductase ternary complex with NADPH and bethotrexate-gamma-tetrazole. Anticancer Drug Des. 7, 483-491.
36. Sawaya, M. R. and J. Kraut (1997) Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry 36, 586-603.
37. + ternary complex. Substrate binding and a model for the transition state. Biochemistry 29, 3263-3277.
38. 13C-enriched methotrexate for NMR studies of drug-enzyme interactions. Heterocycles 25, 507-514.
39. Fierke, C. A., J. K. A. and S. J. Benkovic (1987) Construction and evaluation of the kinetic scheme associated with dihydrofolate reductase from Escherichia coli. Biochemistry 26, 4085-4092.
40. Seeger, D. R., D. B. Cosulich and M. E. Hultquist (1949) Analogs of pteroylglutamic acid. III. 4-amino derivatives. J. Am. Chem. Soc. 71, 1753.
41. Callender, R. and H. Deng (1994) Nonresonance raman difference spectroscopy: a general probe of protein structure, ligand binding, enymatic catalysis, and the structures of other biomacromolecules. Annu. Rev. Biophys. Biomol. Struct. 23, 215-245.
42. Dewar, M. J. S., E. G. Zoebisch, E. G. Healy and J. J. P. Stewart (1985) AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107, 3902-3910.
43. Bowman, W. D. and T. G. Spiro (1980) Fluorescence-free resonance Raman spectra of reduced nicotinamide adenine dinucleotide via ultraviolet excitation. J. Raman Spectrosc. 9, 369-371.
44. Yue, K. T., C. L. Martin, D. Chen, P. Nelson, D. L. Sloan and R. Callender (1986) Raman spectroscopy of oxidized and reduced nicotinamide adenine dinucleotides. Biochemistry 25, 4941-4947.
45. Deng, H., J. Burgner and R. Callender (1992) Raman spectroscopic studies of the effects of substrate binding on coenzymes bound to lactate dehydrogenase. J. Am. Chem. Soc. 114, 7997-8003.
46. Chen, Y. Q., J. Kraut, R. L. Blakley and R. Callender (1994) Determination by Raman spectroscopy of the pKa of N5 of dihydrofolate bound to dihydrofolate reductase: mechanistic implications. Biochemistry 33, 7021-7026.
47. Gready, J. E. (1985) Theoretical studies on the activation of the pterin cofactor in the catalytic mechanism of dihydrofolate reductase. Biochemistry 24, 4761-4766.
48. Williams, J. W., J. F. Morrison and R. G. Duggleby (1979) Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase. Biochemistry 18, 2567-2573.
49. Stone, S. R., J. A. Montgomery and J. F. Morrison (1984) Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogs. Biochem. Pharmacol. 33, 175-179.
50. Appleman, J. R., E. E. Howell, J. Kraut, M. Kuhl and R. L. Blakley (1988) Role of aspartate 27 in the binding of methotrexate to dihydrofolate reductase from Escherichia coli. J. Biol. Chem. 263, 9187-9198.
51. Appleman, J. R., N. Prendergast, T. J. Delcamp, J. H. Freisheim and R. L. Blakley (1988) Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase. J. Biol. Chem. 263, 10304-10313.
52. Tinoco, I., Jr. (1960) Hypochromism in polynucleotides. J. Am. Chem. Soc. 84, 4785-4790.
53. Tomlinson, B. L. and W. L. Peticolas (1970) Conformational dependence of Raman scattering intensities in polyadenylic acid. J. Chem. Phys. 52, 2154-2156.
54. Small, E. W. and W. L. Peticolas (1971) Conformational dependence of the Raman scattering intensities from polynucleotides. III. Order-disorder changes in helical structures. Biopolymers 10, 1377-1416.
55. Howell, E. E., J. E. Villafranca, M. S. Warren, S. J. Oatley and J. Kraut (1986) Functional role of aspartic acid-27 in dihydrofolate reductase revealed by mutagenesis. Science 231, 1123-1128.
56. McGuire, J. J., P. Hsieh and J. R. Bertino (1984) Enzymatic synthesis of polyglutamate derivatives of 7-hydroxymethotrexate. Biochem. Pharmacol. 33, 1355-1361.
57. Fabre, G., I. Fabre, L. H. Matherly, J. P. Cano and I. D. Goldman (1984) Synthesis and properties of 7-hydroxymethotrexate polyglutamyl derivatives in Ehrlich ascites tumor cells in vitro. J. Biol. Chem. 259, 5066-5072.